These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25573)

  • 1. [Management of milder forms of hypertension using new beta-receptor blockaders].
    Pozenel H
    Adv Clin Pharmacol; 1976; 11():99-106. PubMed ID: 25573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Synthesis of new beta-blockaders analogs of bevantolol or alprenolol].
    Bompart J; Pastor G; Giral L; Alvart R
    Ann Pharm Fr; 1987; 45(5):379-87. PubMed ID: 2899414
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in hemodynamics and renal function during the oral administration of betaxolol].
    Pathe M; Schwartz J
    Therapie; 1985; 40(4):209-12. PubMed ID: 2862715
    [No Abstract]   [Full Text] [Related]  

  • 4. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metoprolol, a new cardioselective beta blocking agent in the treatment of arterial hypertension].
    Pedersen OL
    Ugeskr Laeger; 1975 Sep; 137(39):2274-6. PubMed ID: 241148
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug information. Metoprolol (Seloken, Hässle)].
    Kampmann JP
    Ugeskr Laeger; 1975 Dec; 137(51):3046-7. PubMed ID: 837
    [No Abstract]   [Full Text] [Related]  

  • 8. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive therapy with a fixed combination of beta receptor blockers and diuretics].
    Kolloch R; Overlack A; Stumpe KO
    Ther Ggw; 1979 Oct; 118(10):1517-28. PubMed ID: 40314
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of Cordanum in labile hypertension].
    Gerasimiuk PP; Zaporozhets TF; Slobodianik GP
    Vrach Delo; 1982 Nov; (11):29-30. PubMed ID: 6130655
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
    Mattioli G; Ricci S; Bertoncelli P
    Minerva Cardioangiol; 1979; 27(7-8):463-72. PubMed ID: 44898
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparative study of celiprolol and placebo in the treatment of hypertension.
    Capone P; Mayol R
    Br J Clin Pract Suppl; 1985 Jun; 40():65-9. PubMed ID: 2864067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of essential hypertension using a new beta-receptor blockader (timolol maleate) combined with hydrochlorothiazide].
    Heinze A; Wessels F
    Verh Dtsch Ges Inn Med; 1974; 80():272-4. PubMed ID: 4156115
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P; Bellocci F; Santarelli P; Iannarelli M
    Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
    [No Abstract]   [Full Text] [Related]  

  • 16. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 17. Tobanum treatment in mild and medium severity hypertension.
    Udvarhelyi A
    Ther Hung; 1986; 34(3):171-4. PubMed ID: 2894722
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of arotinolol hydrochloride on hemodynamics, catecholamine levels and metabolism in patients with essential hypertension].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Konishi T; Hamada M; Nakano T
    Kokyu To Junkan; 1988 Mar; 36(3):311-5. PubMed ID: 2453908
    [No Abstract]   [Full Text] [Related]  

  • 19. [Celiprolol efficacy and tolerance in the treatment of arterial hypertension].
    Lobos Bejarano JM; Granados Menéndez MI; del Valle González J; Bravo Juega P
    An Med Interna; 1991 Jan; 8(1):52-3. PubMed ID: 1680475
    [No Abstract]   [Full Text] [Related]  

  • 20. [Betaxolol versus nifedipine in the treatment of essential hypertension].
    Steiner A; Hany S; Bättig B; Jenni R; Troesch M; Willimann P; Graf A; Leutenegger F; Angehrn V; Beck G
    Schweiz Rundsch Med Prax; 1988 Oct; 77(41):1101-3. PubMed ID: 2907178
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.